1. Home
  2. PFS vs TARS Comparison

PFS vs TARS Comparison

Compare PFS & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFS
  • TARS
  • Stock Information
  • Founded
  • PFS 1839
  • TARS 2016
  • Country
  • PFS United States
  • TARS United States
  • Employees
  • PFS N/A
  • TARS N/A
  • Industry
  • PFS Savings Institutions
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • PFS Finance
  • TARS Health Care
  • Exchange
  • PFS Nasdaq
  • TARS Nasdaq
  • Market Cap
  • PFS 2.4B
  • TARS 2.8B
  • IPO Year
  • PFS N/A
  • TARS 2020
  • Fundamental
  • Price
  • PFS $18.11
  • TARS $77.39
  • Analyst Decision
  • PFS Strong Buy
  • TARS Strong Buy
  • Analyst Count
  • PFS 5
  • TARS 7
  • Target Price
  • PFS $23.00
  • TARS $69.86
  • AVG Volume (30 Days)
  • PFS 680.0K
  • TARS 461.9K
  • Earning Date
  • PFS 10-29-2025
  • TARS 11-04-2025
  • Dividend Yield
  • PFS 5.35%
  • TARS N/A
  • EPS Growth
  • PFS 100.33
  • TARS N/A
  • EPS
  • PFS 1.96
  • TARS N/A
  • Revenue
  • PFS $836,917,000.00
  • TARS $366,100,000.00
  • Revenue This Year
  • PFS $30.95
  • TARS $139.46
  • Revenue Next Year
  • PFS $10.41
  • TARS $49.91
  • P/E Ratio
  • PFS $9.15
  • TARS N/A
  • Revenue Growth
  • PFS 59.19
  • TARS 182.44
  • 52 Week Low
  • PFS $14.34
  • TARS $38.51
  • 52 Week High
  • PFS $22.24
  • TARS $78.76
  • Technical
  • Relative Strength Index (RSI)
  • PFS 42.13
  • TARS 66.65
  • Support Level
  • PFS $17.71
  • TARS $70.84
  • Resistance Level
  • PFS $19.24
  • TARS $78.76
  • Average True Range (ATR)
  • PFS 0.42
  • TARS 3.29
  • MACD
  • PFS -0.03
  • TARS 0.35
  • Stochastic Oscillator
  • PFS 26.71
  • TARS 88.54

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: